| Code | 46004 | ||||||||||
| MA number | 83/0336/06-S | ||||||||||
| Product Form: | tbl 30x8 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 83 - VASODILATANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 15.08.2006 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Betahistin Actavis 8 mg_16 mg_tbl_08_2022.pdf
|
| PIL: |
PIL_Betahistin Actavis_tbl_07_2023.pdf
|
| Safety feature | Yes |
| Data update: | 16.04.2018 |
